Gilead Sciences’ Post

View organization page for Gilead Sciences

682,878 followers

3mo

We’re proud to be included on the Dow Jones Sustainability World Index and to be recognized as one of the most sustainable pharmaceutical companies. This is the fourth year we’ve been included on the list, and it reflects our commitment to sustainable business practices and transparency on environmental, social and governance issues. By investing in world-class science, improving access to our therapies and breaking down barriers to care, we’re helping create a healthier world for all people. Learn more about our commitments in our ESG Impact Report: https://gilead.inc/3ZLVGIO

8 Comments

tim jonasson

technician at Argonne National Laboratory

3mo

Would my pill pusher (physician) have recommended anything from you?

1 Reaction

FWD Pharma

3mo

Our Future Is Kind®

3mo

Congratulations! 🎊

Trevor J. Cole BHS, MBA-HCM-PM, CCRC, PMP, RN

Transforming the Now and the Future of Clinical Trials Through Collaboration, Information Dissemination, and Tools to GSD

3mo

Congratulations Gilead Sciences what an achievement that requires intention and great stewardship to make the world a better place for all today and in the future!

1 Reaction

Shane Hare

2mo

Well done

Orient Telecoms

3mo

Inspired by Gilead's continuous commitment to sustainability and transparency. Congratulations on being recognized on the Dow Jones Sustainability World Index for the fourth year in a row! Together, let's continue to build a brighter, more sustainable future for all. 🌍 #Sustainability #ESG #Innovation #HealthForAll #SustainableBusiness

Yasmin Mirza, Ph.D. , MBA

Skills and strategies in teaching and assessment (PGCE, FHEA, Worldwide Recognised Tutor). Plan and execute biotech research projects for commercialisation (PMP). Versed in teaching, R&D, and business (PhD, MBA).

3mo

Great to hear!

2 Reactions

Carlos T.

1st Amendment Freedoms

3mo

GodBless America 🇺🇸 and Gileadites

1 Reaction

See more comments

To view or add a comment, sign in

More Relevant Posts

Rupesh P.

Passionate about making meaningful difference with Research, Data Analytics, Consulting and Strategic Partnerships.
9mo Edited
Report this post
The pharmaceutical industry is making significant strides toward sustainability, with companies across the sector implementing various Environmental, Social, and Governance (ESG) initiatives. #ESG #climatechange #sustainability

How are pharma companies addressing sustainability and climate change?

outsourcing-pharma.com
Like Comment
To view or add a comment, sign in
Andrew Barile-Hill

Experienced Scientist and Biotech Instrumentation Sales Specialist
6mo
Report this post
Navigating sustainability in biopharma? Tackling scope 3 emissions—indirect emissions from supply chains and product use—can be tough. Suppliers and biopharma companies need to collaborate more closely to make strides in sustainability. Check out our review and insights: https://cytiva.link/j1es6.
Like Comment
To view or add a comment, sign in
Kal Subramanian
6mo
Report this post
Navigating sustainability in biopharma? Tackling scope 3 emissions—indirect emissions from supply chains and product use—can be tough. Suppliers and biopharma companies need to collaborate more closely to make strides in sustainability. Check out our review and insights: https://cytiva.link/j1es6.
Like Comment
To view or add a comment, sign in
Sarah Potez

Director, Swiss Branch at Cytiva - Account Manager at Cytiva
3mo
Report this post
Navigating sustainability in biopharma? Tackling scope 3 emissions—indirect emissions from supply chains and product use—can be tough. Suppliers and biopharma companies need to collaborate more closely to make strides in sustainability. Check out our review and insights: https://cytiva.link/j1es6.
Like Comment
To view or add a comment, sign in
Seth Cooper, MBA

Principal Regional Marketing Manager, USCAN
3mo
Report this post
Navigating sustainability in biopharma? Tackling scope 3 emissions—indirect emissions from supply chains and product use—can be tough. Suppliers and biopharma companies need to collaborate more closely to make strides in sustainability. Check out our review and insights: https://cytiva.link/j1es6.
Like Comment
To view or add a comment, sign in
Sarah Potez

Director, Swiss Branch at Cytiva - Account Manager at Cytiva
2mo
Report this post
Navigating sustainability in biopharma? Tackling scope 3 emissions—indirect emissions from supply chains and product use—can be tough. Suppliers and biopharma companies need to collaborate more closely to make strides in sustainability. Check out our review and insights: https://cytiva.link/j1es6.
Like Comment
To view or add a comment, sign in
Sharon Vivian

BioProcess Account Manager at Cytiva - Enabling Researchers Developing Innovative Vaccines, Biologic Drugs, and Novel Cell and Gene Therapies
6mo
Report this post
Navigating sustainability in biopharma? Tackling scope 3 emissions—indirect emissions from supply chains and product use—can be tough. Check out our key takeaways from our latest Sustainability Review here: https://cytiva.link/a4vfp.
Like Comment
To view or add a comment, sign in
Susan Hamilton

Author and experienced employee communications professional
6mo
Report this post
Navigating sustainability in biopharma? Tackling scope 3 emissions—indirect emissions from supply chains and product use—can be tough. Check out our key takeaways from our latest Sustainability Review here: https://cytiva.link/a4vfp.
Like Comment
To view or add a comment, sign in

682,878 followers

View Profile Connect

Gilead Sciences’ Post

More Relevant Posts

Explore topics